Wed, March 5, 2025
[ Wed, Mar 05th ]: Fortune
Deloitte is tracking office attendance to decided bonuses for some staff
[ Wed, Mar 05th ]: rnz
Shock and Orr: The sudden resignation of the central bank governor
[ Wed, Mar 05th ]: Huawei
All Intelligent Operations Enables New Growth
[ Wed, Mar 05th ]: Forbes
Trump Speech To Congress Renews Call For No Tax On Tips
[ Wed, Mar 05th ]: Reuters
Dollar Tree appoints former Tyson executive as CFO
[ Wed, Mar 05th ]: manilatimes
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
[ Wed, Mar 05th ]: MarketWatch
Say hello to the 10% savings account - and 9 more .. of the highest APY savings accounts in March 2025
[ Wed, Mar 05th ]: business
Treasury bill rate decline: Macroeconomic and fiscal implications
[ Wed, Mar 05th ]: Politico
Trump's go-it-alone vision for America
[ Wed, Mar 05th ]: Kiplinger
10 Ways to Refine Your Financial Plan for a More Secure Future
[ Wed, Mar 05th ]: Impacts
Unmasking Cryptocurrency Trading Schemes: The Ris .. , and Fake Investment Schemes in the Digital Age.
[ Wed, Mar 05th ]: CNET
Did You Receive a 1099-K? Make Sure You Don't Make This Costly Mistake
[ Wed, Mar 05th ]: GlobalData
China, Canada retaliate against US tariffs
[ Wed, Mar 05th ]: Fortune
RGA and Equitable pen $32 billion reinsurance dea .. uture earnings as Wall Street issues hold ratings
[ Wed, Mar 05th ]: IPPMEDIA
Executives, business leaders to meet in Dar for women's rights, empowerment
[ Wed, Mar 05th ]: Zawya
PIF and SACE sign MoU for up to $3bln to promote Italian companies' engagement in Saudi Arabia
[ Wed, Mar 05th ]: MSN
Kenya's private sector growth holds steady in February, outlook dim
[ Wed, Mar 05th ]: IPPMEDIA
Banks, finance, investments counters spur DSE indices movement on month's opening
[ Wed, Mar 05th ]: Reuters
UK aims to speed up defence contracts, finance minister says
[ Wed, Mar 05th ]: richest
Elon Musk fails in bid to block OpenAI becoming a for-profit business
[ Wed, Mar 05th ]: Mint
How Sebi's serial crackdown crimped F&O volumes and crashed broking-firm stocks
[ Wed, Mar 05th ]: Investopedia
Kash Patel Net Worth: Here's How Trump's FBI Director Made His Money
[ Wed, Mar 05th ]: Tuko
How to Determine Financial Stability of SACCOs in Kenya: Factors to Consider Before Joining
[ Wed, Mar 05th ]: MSN
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2024 Earnings Call Transcript
[ Wed, Mar 05th ]: CNN
Fact-checking Trump's address to Congress
[ Wed, Mar 05th ]: ThePrint
Stock market opens in green despite Trump's reciprocal tariffs announcement from April 2
Tue, March 4, 2025
[ Tue, Mar 04th ]: BBC
Zelensky ready to work under Trump's 'strong leadership' after 'regrettable' showdown
[ Tue, Mar 04th ]: Moneyweb
Budget 2025: 'There's no agreement yet' - Steenhuisen
[ Tue, Mar 04th ]: Investopedia
Medicare Advantage vs. Original Medicare: Which Should You Trust Your Health To?
[ Tue, Mar 04th ]: Fortune
Elon Musk is 'the investor of our age' and won't .. e distracted by DOGE, Tesla bull Cathie Wood says
[ Tue, Mar 04th ]: CNN
Lutnick: US could announce trade deal Wednesday with Mexico and Canada after imposing tariffs
[ Tue, Mar 04th ]: Variety
Behind the 'Sickening' Collapse of Technicolor an .. re Is Sending Shockwaves Through the VFX Industry
[ Tue, Mar 04th ]: CNET
Tariffs Explained: What They Mean for You as Canada-Mexico Duties Take Effect
[ Tue, Mar 04th ]: Fortune
Target CEO joins swarm of Fortune 500 executives .. as Trump's tariff fallout hits the grocery aisle
[ Tue, Mar 04th ]: MarketWatch
Revenge of the killer tomato tariffs
[ Tue, Mar 04th ]: Newspoint
Retirement: Have you reached 45 years of age and .. t done any retirement planning? Try this method..
[ Tue, Mar 04th ]: Forbes
Zelensky's Fox Interview After Oval Office Drama Draws 6 Million Viewers
[ Tue, Mar 04th ]: MarketWatch
This bank is offering a $10K sign-up bonus - and 9 more of the biggest bank bonuses in March 2025
[ Tue, Mar 04th ]: timesnownews
University of East Anglia Launches BSc in International Finance
[ Tue, Mar 04th ]: Kiplinger
Stock Market Today: Dow Drops 670 Points on Trade War Effect
[ Tue, Mar 04th ]: Kiplinger
Tax Implications of the Social Security Fairness Act: Are You Prepared?
[ Tue, Mar 04th ]: Reuters
Goldman Sachs may cut more than 1,300 employees in annual review, source says
[ Tue, Mar 04th ]: Indiatimes
Breaking News Live Updates: Trump's new tariffs o .. a take effect; China retaliates with higher taxes
[ Tue, Mar 04th ]: AOL
Nearly half of company leaders say they plan to s .. ir DEI policies despite the Trump-fueled backlash
[ Tue, Mar 04th ]: MSN
Sagittarius Daily Horoscope Today (Nov 22- Dec 21), March 05, 2025: Be hardworking and polite!
[ Tue, Mar 04th ]: Wired
People Are Paying Millions to Dine With Donald Trump at Mar-a-Lago
[ Tue, Mar 04th ]: Forbes
20 Essential Skills For Financial Leaders To Thrive In 2025
[ Tue, Mar 04th ]: MSN
Trump's tariffs on Mexico and Canada go into effect: Here's how it will affect Georgia

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2024 Earnings Call Transcript

  Copy link into your clipboard //business-finance.news-articles.net/content/202 .. asdaq-ocul-q4-2024-earnings-call-transcript.html
  Print publication without navigation Published in Business and Finance on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Q4 2024 Earnings Call Transcript March 3, 2025 Ocular Therapeutix, Inc. misses on earnings expectations. Reported EPS is $-0.29 EPS, expectations were $-0.24. Operator: Good morning, and welcome to the Ocular Therapeutix Fourth Quarter 2024 Earnings Conference Call.
The article provides a transcript of the Q4 2024 earnings call for Ocular Therapeutix Inc., a biopharmaceutical company focused on eye care. During the call, CEO Antony Mattessich and CFO Donald Notman discussed the company's financial performance, operational updates, and future outlook. Key points included the progress of their lead product candidate, OTX-TKI, for the treatment of wet age-related macular degeneration (wet AMD), with positive interim data from the ongoing Phase 1 HELIOS trial. They also touched on the development of other pipeline products, strategic partnerships, and the company's efforts to manage costs while advancing their clinical programs. The call highlighted a focus on innovation in ophthalmic treatments, aiming to address unmet medical needs in eye diseases.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/ocular-therapeutix-inc-nasdaq-ocul-q4-2024-earnings-call-transcript/ar-AA1AdUnD ]